Evaluation of changes in the global longitudinal strain for left ventricular function before and after eight weeks of taking high dose of atorvastatin in patients with coronary slow flow phenomenon.

Inclusion and exclusion criteria Exclusion criteria were as follows: a history of allergy to atorvastatin, an increasing trend in the blood concentration of creatine kinase, symptoms of myositis while taking atorvastatin, unavailability of files in the archives of Farshchian Hospital, having visited Farshchian Hospital and refusal to continue treatment in that hospital, having visited Farshchian Hospital and transferal to

also in 63,971 other papers